These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 23298559)

  • 1. Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges.
    Zannad F; Stough WG; Regnault V; Gheorghiade M; Deliargyris E; Gibson CM; Agewall S; Berkowitz SD; Burton P; Calvo G; Goldstein S; Verheugt FW; Koglin J; O'Connor CM
    Int J Cardiol; 2013 Sep; 167(5):1772-82. PubMed ID: 23298559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA;
    Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications.
    Dávila DF; Núñez TJ; Odreman R; de Dávila CA
    Int J Cardiol; 2005 Jun; 101(3):343-6. PubMed ID: 15907399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of statin therapy on the development and progression of heart failure: mechanisms and clinical trials.
    Khush KK; Waters DD
    J Card Fail; 2006 Oct; 12(8):664-74. PubMed ID: 17045188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation in patients with heart failure.
    Bhatia RS; Ouzounian M; Tu JV; Liu PP; Lee DS
    Cardiovasc Hematol Agents Med Chem; 2009 Jul; 7(3):193-7. PubMed ID: 19689257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the optimal medical management of ischemic heart failure?
    Cleland JG; Alamgir F; Nikitin NP; Clark AL; Norell M
    Prog Cardiovasc Dis; 2001; 43(5):433-55. PubMed ID: 11251129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurohormonal mechanisms in cardiac insufficiency. Possible therapeutic implications].
    Iannetti MV; Vallebona A; Perocchio M
    Minerva Cardioangiol; 1993 Mar; 41(3):81-9. PubMed ID: 8510813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cardiac resynchronization therapy on systemic inflammation and neurohormonal pathways in heart failure.
    Tarquini R; Guerra CT; Porciani MC; Michelucci A; Padeletti M; Ricciardi G; Chiostri M; Jelic S; Padeletti L
    Cardiol J; 2009; 16(6):545-52. PubMed ID: 19950091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure in pediatric patients.
    Hoch M; Netz H
    Thorac Cardiovasc Surg; 2005 Feb; 53 Suppl 2():S129-34. PubMed ID: 15704035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurohormonal and inflammatory markers as predictors of short-term outcome in patients with heart failure and cardiac resynchronization therapy.
    Glick A; Michowitz Y; Keren G; George J
    Isr Med Assoc J; 2006 Jun; 8(6):391-5. PubMed ID: 16833167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical therapy and prognosis in chronic heart failure. Lessons from clinical trials.
    Ramahi TM; Lee FA
    Cardiol Clin; 1995 Feb; 13(1):5-26. PubMed ID: 7796432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should all acutely ill medical patients be treated with antithrombotic drugs? A review of the interventional trials.
    Violi F; Perri L; Loffredo L
    Thromb Haemost; 2013 Apr; 109(4):589-95. PubMed ID: 23426236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical use of markers of neurohormonal activation in heart failure].
    Roig Minguell E
    Rev Esp Cardiol; 2004 Apr; 57(4):347-56. PubMed ID: 15104989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombo-embolism and antithrombotic therapy for heart failure in sinus rhythm. A joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Ponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marin F; Lane DA;
    Eur J Heart Fail; 2012 Jul; 14(7):681-95. PubMed ID: 22611046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurohormonal assessment in heart failure: from the sophisticated laboratory to practical indications].
    Dei Cas L; Metra M; Visioli O
    G Ital Cardiol; 1993 Feb; 23(2):193-204. PubMed ID: 8098306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stent thrombosis in the era of drug eluting stents.
    Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antithrombotic prophylaxis in patients with ventricular dysfunction: critical review of the literature and new perspectives].
    Scardi S; Mazzone C
    Ital Heart J Suppl; 2003 Mar; 4(3):201-9. PubMed ID: 12784754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High output heart failure.
    Mehta PA; Dubrey SW
    QJM; 2009 Apr; 102(4):235-41. PubMed ID: 18990720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of endothelial shear stress in stent restenosis and thrombosis: pathophysiologic mechanisms and implications for clinical translation.
    Koskinas KC; Chatzizisis YS; Antoniadis AP; Giannoglou GD
    J Am Coll Cardiol; 2012 Apr; 59(15):1337-49. PubMed ID: 22480478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of endothelins in congestive heart failure.
    Moe GW; Rouleau JL; Nguyen QT; Cernacek P; Stewart DJ
    Can J Physiol Pharmacol; 2003 Jun; 81(6):588-97. PubMed ID: 12839270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.